GBT Technologies Inc., is continuing its research with AI based, robotics technology for the medical field. The research is now focused on remote operation robotics for use in medical procedures.
Remote controlled robots, using mechanical arms are aimed to assist surgeons providing significant advantages when it comes to delicate surgeries and procedures. A surgeon may operate a robotic mechanism using a remote computer or a console.
The advantage of using a robotic system is producing high precision incisions and procedures that are much harder to be done by a human hand. Extremely small movements and accurate tissue removal within small areas, can be efficiently achieved using AI based computer program that is controlling a robotic arm.
The research will focus on developing precise algorithms for robotic movements within small regions along with machine vision procedures as the guiding “eyes”.
“As part of our ongoing AI based robotic research program we are now investigating into remote operated robotics for medical purposes. For the past decade we have witnessed a significant development in the field of robotic systems for the medical field in a wide verity of domains. Mechanical robotic arms along with algorithmic control software are emerging for complicated surgeries and procedures.
Due to the advantage of high precision movements and accurate organs identification, robotic systems are becoming a common operating rooms equipment to assist surgeons and physicians with diagnostics and surgeries. An example for preventative diagnostic procedure is a colonoscopy where a machine vision can be of a great assistance to view and analyze objects for suspicious abnormalities.
We believe this type of procedure can be done via a remote-controlled robotic system, supervised by a surgeon. The robotic system is aimed to be surgeon operated via a remote computer program or a console performing minimally invasive procedures.
We believe the combination of machine vision as the system’s eyes and a high accuracy mechanical control can create a whole world of possibilities for research and development of efficient medical, AI based, robotic applications. We are excited to conduct this research which we consider as the forefront of medical robotic technologies, introducing better health care possibilities for patients and surgeons.” Stated Dr. Rittman the Company’s CTO.
There is no guarantee that the Company will be successful in researching, developing or implementing this research. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.